Scholarlink

<p>Pharmacopoeia reference standards play a vital role in the pharmaceutical industry by setting benchmarks for the quality, purity and consistency of drugs. Established by official pharmacopeia bodies like British Pharmacopoeia Commission, European Pharmacopoeia Commission, Indian Pharmacopoeia Commission and United States Pharmacopeia; these standards provide the authoritative guidelines for analytical and quality control methods and ensure that pharmaceutical products worldwide meet regulatory requirements and remain safe for consumers. Despite their critical importance, the comprehensive scientific and regulatory processes involved in developing pharmacopoeial reference standards remain insufficiently documented in accessible literature, creating knowledge gaps for researchers, regulators and industry stakeholders. The current article addresses these gaps by detailing the key stages of pharmacopoeia reference standard development, drawing on the principles outlined in ISO 17034 (general requirements for the competence of reference material producers), ISO Guide 31 (covering the contents of certificates and labels for reference materials), ISO Guide 34 (general requirements for the competence of reference material producers), ISO/Guide 35:2017 (guidance on characterization and assessment of homogeneity and stability of reference materials) and WHO TRS 943 (general guidelines for the establishment, maintenance and distribution of chemical reference substances). Particular emphasis is placed on the development of Indian Pharmacopoeia Reference Standards, underscoring their pivotal role in analytical testing, method validation, quality control, and the broader framework of global pharmaceutical harmonization. Moreover, it elucidates how rigorous adherence to pharmacopoeial reference standards enables the pharmaceutical industry to ensure the safety and efficacy of medicinal products, thereby safeguarding public health and fostering sustained confidence in therapeutic interventions.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Indian Pharmacopoeia Reference Standards: A Key Tool to Regulate the Quality of Pharmaceuticals

  • 期刊论文

  • 发表日期：

    2026年1月28日

查看全文
  • Arvind Kumar Sharma,
  • Shruti Rastogi,
  • Priyanka Nagar,
  • Suraj Tiwari,
  • Anuj Prakash Yadav,
  • Robin Kumar,
  • Vivekanandan Kalaiselvan

摘要

Pharmacopoeia reference standards play a vital role in the pharmaceutical industry by setting benchmarks for the quality, purity and consistency of drugs. Established by official pharmacopeia bodies like British Pharmacopoeia Commission, European Pharmacopoeia Commission, Indian Pharmacopoeia Commission and United States Pharmacopeia; these standards provide the authoritative guidelines for analytical and quality control methods and ensure that pharmaceutical products worldwide meet regulatory requirements and remain safe for consumers. Despite their critical importance, the comprehensive scientific and regulatory processes involved in developing pharmacopoeial reference standards remain insufficiently documented in accessible literature, creating knowledge gaps for researchers, regulators and industry stakeholders. The current article addresses these gaps by detailing the key stages of pharmacopoeia reference standard development, drawing on the principles outlined in ISO 17034 (general requirements for the competence of reference material producers), ISO Guide 31 (covering the contents of certificates and labels for reference materials), ISO Guide 34 (general requirements for the competence of reference material producers), ISO/Guide 35:2017 (guidance on characterization and assessment of homogeneity and stability of reference materials) and WHO TRS 943 (general guidelines for the establishment, maintenance and distribution of chemical reference substances). Particular emphasis is placed on the development of Indian Pharmacopoeia Reference Standards, underscoring their pivotal role in analytical testing, method validation, quality control, and the broader framework of global pharmaceutical harmonization. Moreover, it elucidates how rigorous adherence to pharmacopoeial reference standards enables the pharmaceutical industry to ensure the safety and efficacy of medicinal products, thereby safeguarding public health and fostering sustained confidence in therapeutic interventions.

Graphical Abstract